Yeong J. Lim

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014-2022: An England-wide cohort study from the UNCOVER group.

Trends and socio-economic disparities in chronic lymphocytic leukaemia 2014-2022: An England-wide cohort study from the UNCOVER group.

Journal: British journal of haematology

Published: April 02, 2026

Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.

Coronavirus disease 2019 (COVID-19) risk and evolving treatment patterns in follicular lymphoma during the pandemic: Insights from the PETReA trial.

Journal: British journal of haematology

Published: February 18, 2026

Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia.

Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia.

Journal: Scientific reports

Published: March 11, 2025

Influence of polyfunctional Tbet+ T cells on specific clinical events in chronic lymphocytic leukaemia.

Influence of polyfunctional Tbet+ T cells on specific clinical events in chronic lymphocytic leukaemia.

Journal: Frontiers in immunology

Published: November 14, 2024

Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.

Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.

Journal: British journal of haematology

Published: April 08, 2024

Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity.

Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 03, 2023

COVID-19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta-analysis.

COVID-19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta-analysis.

Journal: EJHaem

Published: February 28, 2022

Autologous Hematopoietic Stem Cell Transplantation for Behçet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Autologous Hematopoietic Stem Cell Transplantation for Behçet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.

Journal: Frontiers in immunology

Published: December 07, 2020

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.

Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.

Journal: British journal of haematology

Published: January 06, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026